drugset / Trial / NCT04648696
Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the safety and outcomes associated between the two treatment modalities
Timeline
- Start
- 2021-03-03
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vancomycin | Other / unclassified | — | Intravenous |